Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 6
2004 3
2005 4
2006 3
2008 5
2009 5
2010 5
2011 3
2012 2
2013 4
2014 5
2015 10
2016 9
2017 9
2018 10
2019 8
2020 5
2021 5
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

94 results
Results by year
Filters applied: . Clear all
Page 1
Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study.
Hippisley-Cox J, Coupland CA, Mehta N, Keogh RH, Diaz-Ordaz K, Khunti K, Lyons RA, Kee F, Sheikh A, Rahman S, Valabhji J, Harrison EM, Sellen P, Haq N, Semple MG, Johnson PWM, Hayward A, Nguyen-Van-Tam JS. Hippisley-Cox J, et al. Among authors: johnson pwm. BMJ. 2021 Sep 17;374:n2244. doi: 10.1136/bmj.n2244. BMJ. 2021. PMID: 34535466 Free PMC article.
Primary mediastinal large B-cell lymphoma.
Martelli M, Ferreri A, Di Rocco A, Ansuinelli M, Johnson PWM. Martelli M, et al. Among authors: johnson pwm. Crit Rev Oncol Hematol. 2017 May;113:318-327. doi: 10.1016/j.critrevonc.2017.01.009. Epub 2017 Jan 21. Crit Rev Oncol Hematol. 2017. PMID: 28318892 Review.
Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma.
Lim SH, Campbell N, Johnson M, Joseph-Pietras D, Collins GP, O'Callaghan A, Fox CP, Ahearne M, Johnson PWM, Goldblatt D, Davies AJ. Lim SH, et al. Among authors: johnson pwm. Lancet Haematol. 2021 Aug;8(8):e542-e544. doi: 10.1016/S2352-3026(21)00199-X. Epub 2021 Jul 2. Lancet Haematol. 2021. PMID: 34224667 Free PMC article. Clinical Trial. No abstract available.
Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy.
Sha C, Barrans S, Cucco F, Bentley MA, Care MA, Cummin T, Kennedy H, Thompson JS, Uddin R, Worrillow L, Chalkley R, van Hoppe M, Ahmed S, Maishman T, Caddy J, Schuh A, Mamot C, Burton C, Tooze R, Davies A, Du MQ, Johnson PWM, Westhead DR. Sha C, et al. Among authors: johnson pwm. J Clin Oncol. 2019 Jan 20;37(3):202-212. doi: 10.1200/JCO.18.01314. Epub 2018 Dec 3. J Clin Oncol. 2019. PMID: 30523719 Free PMC article.
Michels J, Johnson PW, Packham G. Michels J, et al. Among authors: johnson pw. Int J Biochem Cell Biol. 2005 Feb;37(2):267-71. doi: 10.1016/j.biocel.2004.04.007. Int J Biochem Cell Biol. 2005. PMID: 15474972 Review.
Smart salvage treatment for Hodgkin lymphoma.
Johnson PWM. Johnson PWM. Blood. 2022 Jun 23;139(25):3563-3564. doi: 10.1182/blood.2022016274. Blood. 2022. PMID: 35737409 No abstract available.
Response-adapted therapy in Hodgkin lymphoma.
Broadfoot J, Johnson PWM. Broadfoot J, et al. Among authors: johnson pwm. Hematol Oncol. 2017 Jun;35 Suppl 1:33-36. doi: 10.1002/hon.2398. Hematol Oncol. 2017. PMID: 28591415 Review. No abstract available.
Optimizing therapy in advanced-stage Hodgkin lymphoma.
Lim SH, Johnson PWM. Lim SH, et al. Among authors: johnson pwm. Blood. 2018 Apr 12;131(15):1679-1688. doi: 10.1182/blood-2017-09-772640. Epub 2018 Mar 2. Blood. 2018. PMID: 29500173 Free article. Review.
Options for first line therapy of Hodgkin lymphoma.
Longley J, Johnson PWM. Longley J, et al. Among authors: johnson pwm. Hematol Oncol. 2019 Jun;37 Suppl 1(Suppl Suppl 1):82-86. doi: 10.1002/hon.2597. Hematol Oncol. 2019. PMID: 31187527 Free PMC article. Review. No abstract available.
94 results